Search
Bicara Therapeutics Inc
BCAXAdd to Watchlist
23.640USD
-0.070-0.30%
Close 09-09 16:00（ET）
1.56BMarket Cap
LossP/E TTM
Shareholding Stats
Updated: Sun, May 10
Updated: Sun, May 10
Shareholders
Shareholder Types
Shareholders
Shareholders
Proportion
RA Capital Management, LP
11.04%
T. Rowe Price Investment Management, Inc.
10.05%
Biocon Ltd.
8.41%
Invus Public Equities Advisors, LLC
7.94%
Vestal Point Capital, LP
5.44%
Other
57.11%
Shareholders
Shareholders
Proportion
RA Capital Management, LP
11.04%
T. Rowe Price Investment Management, Inc.
10.05%
Biocon Ltd.
8.41%
Invus Public Equities Advisors, LLC
7.94%
Vestal Point Capital, LP
5.44%
Other
57.11%
Shareholder Types
Shareholders
Proportion
Investment Advisor
43.95%
Investment Advisor/Hedge Fund
19.24%
Venture Capital
14.47%
Hedge Fund
9.57%
Corporation
8.96%
Private Equity
4.91%
Research Firm
1.80%
Individual Investor
1.28%
Bank and Trust
0.17%
Institutional Shareholding
Updated: Wed, Apr 1
Updated: Wed, Apr 1
Reporting Period
No. of institutions
Shares Held
Proportion
Change
2026Q1
287
61.73M
94.10%
-4.15M
2025Q4
224
50.30M
113.92%
-100.00
2025Q3
224
50.29M
114.26%
-993.95K
2025Q2
199
51.28M
94.95%
+2.59M
2025Q1
174
48.67M
90.18%
-499.81K
2024Q4
146
46.83M
73.19%
+7.00M
2024Q3
76
39.67M
0.00%
+39.67M
Shareholder Activity
Name
Shares Held
Proportion
Change
Chg %
Date
RA Capital Management, LP
7.26M
11.08%
+300.00K
+4.31%
Feb 26, 2026
T. Rowe Price Investment Management, Inc.
3.24M
4.94%
+2.77M
+596.45%
Dec 31, 2025
Biocon Ltd.
5.52M
8.44%
+5.41M
+4671.98%
Apr 14, 2025
Invus Public Equities Advisors, LLC
5.22M
7.97%
--
--
Dec 31, 2025
Vestal Point Capital, LP
3.58M
5.46%
-1.52M
-29.90%
Dec 31, 2025
Red Tree Management, LLC
3.17M
4.84%
--
--
Dec 31, 2025
TPG Capital, L.P.
3.01M
4.6%
--
--
Dec 31, 2025
Deep Track Capital LP
2.75M
4.2%
+136.00K
+5.20%
Feb 12, 2026
Janus Henderson Investors
2.65M
4.04%
+2.65M
--
Dec 31, 2025
Fidelity Management & Research Company LLC
2.41M
3.68%
+773.38K
+47.18%
Dec 31, 2025
View more
Related ETFs
Updated: Sat, Dec 6
Updated: Sat, Dec 6
Name
Proportion
Virtus LifeSci Biotech Clinical Trials ETF
0.95%
Hypatia Women CEO ETF
0.37%
ALPS Medical Breakthroughs ETF
0.37%
Fidelity Enhanced Small Cap ETF
0.06%
T Rowe Price Small-Mid Cap ETF
0.05%
JPMorgan BetaBuilders US Small Cap Equity ETF
0.03%
iShares Russell 2000 Value ETF
0.03%
ProShares Hedge Replication ETF
0.02%
iShares Russell 2000 ETF
0.02%
Global X Russell 2000 ETF
0.02%
View more
Virtus LifeSci Biotech Clinical Trials ETF
Proportion0.95%
Hypatia Women CEO ETF
Proportion0.37%
ALPS Medical Breakthroughs ETF
Proportion0.37%
Fidelity Enhanced Small Cap ETF
Proportion0.06%
T Rowe Price Small-Mid Cap ETF
Proportion0.05%
JPMorgan BetaBuilders US Small Cap Equity ETF
Proportion0.03%
iShares Russell 2000 Value ETF
Proportion0.03%
ProShares Hedge Replication ETF
Proportion0.02%
iShares Russell 2000 ETF
Proportion0.02%
Global X Russell 2000 ETF
Proportion0.02%